Article · 3 Nov 2026
Research articlePublished 16 Dec 2015
Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We investigate whether three common polymorphisms in ERCC1 and ERCC2 are predictor factors for the chemotherapy response, as well as the clinic outcome of patients with gastric cancer. Between May 2011 and May 2013, 263 patients with gastric cancer who were newly diagnosed by histopathology were enrolled in our study. Genotyping of the ERCC1 rs11615 and rs3212986, and ERCC2 rs1799793 polymorphisms were conducted by the polymerase chain reaction-restriction fragment length polymorphism assay. Patients carrying the TT genotype and TT+CT genotype of ERCC1 rs11615 were associated with poorer response to chemotherapy and shorter survival times when compared with the CC genotype. In conclusion, our results suggested that the ERCC1 rs11615 polymorphism in the DNA repair pathways can be used as predictive factors to the clinical outcome of patients with gastric cancer.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Genetics and Molecular Research.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalGenetics and Molecular Research
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “G. Zhong”
- BylineArticles whose byline prints “H.K. Li”
- BylineArticles whose byline prints “T. Shan”
- BylineArticles whose byline prints “N. Zhang”